Ott I, Neumann F J, Kenngott S, Gawaz M, Schömig A
Deutsches Herzzentrum der Technischen Universität München, Germany.
Am J Cardiol. 1998 Oct 15;82(8):938-42. doi: 10.1016/s0002-9149(98)00509-8.
This study sought to investigate monocyte procoagulant activity and Mac-1 expression after successful percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction (AMI). An increased leukocyte count is an important risk factor for subsequent adverse cardiac events in AMI. Cellular procoagulant responses may contribute to the risk of thrombotic events after AMI. In 20 patients with AMI serial venous blood samples were obtained before, 4, 8 hours, and daily after direct PTCA. Twenty patients with elective PTCA served as a control group. We measured leukocyte procoagulant activity with a 1-stage clotting assay, Mac-1 expression of monocytes by flow cytometry, concentrations of tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, and IL-8 using immunoassays. Forty-eight hours after PTCA in patients with AMI, an increase in systemic IL-6 and C-reactive concentrations was found (p = 0.001, p = 0.008) associated with an increase in monocyte Mac-1 expression by 49 +/- 18% (p = 0.04) and followed by an increase in monocyte procoagulant activity by 140 +/- 63% 72 hours after PTCA (p = 0.01). None of these changes were detectable in the control group. No changes in the concentrations of the cytokines IL-1beta, tumor necrosis factor-alpha, or IL-8 were found. The present study demonstrates an increase in procoagulant activity along with an increase in Mac-1 expression on circulating monocytes after successful PTCA in AMI associated with an increase in systemic IL-6. These cellular procoagulant responses may limit the clinical benefit from timely reperfusion.
本研究旨在探讨急性心肌梗死(AMI)患者成功进行经皮腔内冠状动脉成形术(PTCA)后单核细胞促凝活性及Mac-1表达情况。白细胞计数升高是AMI患者随后发生不良心脏事件的重要危险因素。细胞促凝反应可能会增加AMI后血栓形成事件的风险。对20例AMI患者在直接PTCA术前、术后4小时、8小时及每日采集系列静脉血样本。20例行择期PTCA的患者作为对照组。我们采用一步凝血试验测定白细胞促凝活性,通过流式细胞术检测单核细胞的Mac-1表达,使用免疫分析法测定肿瘤坏死因子-α、白细胞介素(IL)-1β、IL-6和IL-8的浓度。AMI患者PTCA术后48小时,发现全身IL-6和C反应蛋白浓度升高(p = 0.001,p = 0.008),同时单核细胞Mac-1表达增加49±18%(p = 0.04),随后在PTCA术后72小时单核细胞促凝活性增加140±63%(p = 0.01)。对照组未检测到这些变化。细胞因子IL-1β、肿瘤坏死因子-α或IL-8的浓度未发现变化。本研究表明,AMI患者成功进行PTCA后,循环单核细胞的促凝活性增加,同时Mac-1表达增加,这与全身IL-6升高有关。这些细胞促凝反应可能会限制及时再灌注带来的临床益处。